Q1 2017 Rockwell Medical Inc Earnings Call
Conference Call Rockwell Medical Inc
Rockwell Medical Inc Conference call will be held on May 9, 2017. During the earnings conference call's session Rockwell Medical Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Rockwell Medical Inc for this information
Schedule an online conference with QCONF conference service and get 5 free calls with online conferencing.
Rockwell Medical, Inc., incorporated in the state of Michigan in 1996, is a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis (HD) (also referred to as "dialysis"). Rockwell's lead branded drug, Triferic® was approved by U.S. Food and Drug Administration ("FDA") in late January 2015. Triferic® has the distinction of being the first drug in its class to be indicated for iron maintenance compared to other intravenous iron drugs that are indicated for iron repletion. Triferic® is a unique iron compound that is delivered to hemodialysis patients via dialysate, replacing the ongoing iron loss that occurs during their dialysis treatment.Read more Conference Call